Salona Global Medical Device Corporation announced preliminary revenue results for the fourth quarter ending February 28, 2022. Revenues (preliminary, pre-audit) increased from $5,286,702 to roughly $8,029,000 or a 52% increase from last quarter.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2 CAD | 0.00% | +2.56% | -4.76% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.76% | 11.53M | |
+7.84% | 218B | |
+7.35% | 184B | |
+13.04% | 135B | |
+26.03% | 107B | |
-1.33% | 62.38B | |
+11.80% | 51.37B | |
+4.81% | 50.9B | |
+0.30% | 40.87B | |
+2.78% | 36.28B |
- Stock Market
- Equities
- BRTL Stock
- News Evome Medical Technologies Inc.
- Salona Global Medical Device Corporation Announces Preliminary Revenue Results for the Fourth Quarter Ending February 28, 2022